I'm LongbridgeAI, I can summarize articles.Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00. Chen covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Amgen. According to TipRanks, Chen has an average return of 6.9% and a 53.61% success rate on recommended stocks. In addition to Scotiabank, AbbVie also received a Buy from RBC Capital’s Trung Huynh in a report issued on September 29. However, on the same day, Citi maintained a Hold rating on AbbVie (NYSE: ABBV).
Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00.
Chen covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Amgen. According to TipRanks, Chen has an average return of 6.9% and a 53.61% success rate on recommended stocks.
In addition to Scotiabank, AbbVie also received a Buy from RBC Capital’s Trung Huynh in a report issued on September 29. However, on the same day, Citi maintained a Hold rating on AbbVie (NYSE: ABBV).